ormulation technology for stabilized lipid-based nanoparticles (LNPs)

This was largely made possible by major advances in the formulation technology for stabilized lipid-based nanoparticles (LNPs). Design of the cationic ionizable lipids, which are a key component of the LNP formulations, with an acid dissociation constant (pKa) close to the early endosomal pH, would not only ensure effective encapsulation of mRNA into the stabilized lipoplexes within the LNPs, but also its subsequent endosomal release into the cytoplasm after endocytosis.
Unlike other gene therapy modalities, which require nuclear delivery, the site of action for exogenous mRNA vaccines is the cytosol where they get translated into antigenic proteins and thereby elicit an immune response. LNPs also protect the mRNA against enzymatic degradation by the omnipresent ribonucleases (RNases). Cationic nano emulsion (CNE) is also explored as an alternative and relatively thermostable mRNA vaccine delivery vehicle.
In this review, we have summarized the various delivery strategies explored for more details joplink Recombinant Human Serine  mRNA vaccines, including naked mRNA injection; ex vivo loading of dendritic cells; CNE; cationic peptides; cationic polymers, and finally the clinically successful COVID-19 LNP vaccines  (Pfizer/BioNTech and Moderna vaccines)-their components, design principles, formulation parameter optimization, and stabilization challenges. Despite the clinical success of LNP-mRNA vaccine formulations, there is a specific need to enhance their storage stability above 0 °C for these lifesaving vaccines to reach the developing.

Understanding the role of microperimetry in glaucoma

The present narrative review attempts to provide an overview on the use of microperimetry or fundus-driven perimetry in glaucoma, considering the clinical use, the different strategies and limits compared to standard automated perimetry.
 An electronic database (PubMed and Medline) search was performed of articles of any type published in the English language between 1998 and 2020 with a combination of the following terms: microperimetry, glaucoma, primary open-angle chronic glaucoma, visual field, Humphrey visual field, fundus automated perimetry.
All the original articles, case reports, and short series analyzed were included in the present review, offering an excursus on the strengths and limitations characterizing the use of microperimetry in glaucomatous patients. The characteristics of a recently introduced fundus-driven perimetry Compass (CMP; Centervue, Padua, Italy) were also included.
Although there remain several contradictions regarding routine use of microperimetry and the restricted research on this topic limits our ability to draw firm conclusions, microperimetry may be preferable in cases of localized retinal nerve fiber layer defects in patients with primary open-angle glaucoma and normal visual field. However, standard automated perimetry remains the gold standard for monitoring glaucoma, especially in patients with diffuse retinal nerve fiber layer impairment and visual field defects. The newly introduced Compass device can potentially provide a more accurate structural-functional evaluation than standard automated perimetry and can therefore produce superior testing reliability.

Ligand-Directed GPCR Antibody Discovery

Developing affinity reagents recognizing and modulating G-protein coupled receptors (GPCR) function by traditional animal immunization or in vitro screening methods is challenging. Some anti-GPCR antibodies exist on the market, but the success rate of development is still poor compared with antibodies targeting soluble or peripherally anchored proteins.

  • More importantly, most of these antibodies do not modulate GPCR function. The current pipeline for antibody development primarily screens for overall affinity rather than functional epitope recognition. We developed a new strategy utilizing natural ligand affinity to generate a library of antibody variants with an inherent bias toward the active site of the GPCR.
  • Instead of using phage libraries displaying antibodies with random CDR sequences at polymorphism sites observed in natural immune repertoire sequences, we generated focused antibody libraries with a natural ligand encoded within or conjugated to one of the CDRs or the N-terminus.
  • To tailor antibody binding to the active site, we limited the sequence randomization of the antibody in regions holstering the ligand while leaving the ligand-carrying part unaltered in the first round of randomization. With hits from the successful first round, the second round of randomization of the ligand-carrying part was then performed to eliminate the bias of the ligand.
  • Based on our results on three different GPCR targets, the proposed pipeline will enable the rapid generation of functional antibodies (both agonists and antagonists) against high-value targets with poor function epitope exposures including GPCR, channels, transporters as well as cell surface targets whose binding site is heavily masked by glycosylation.

endohedral trihedral metallo-borospherenes with spherical aromaticity

It is well-known that transition-metal-doping induces dramatic changes in the structures and bonding of small boron clusters, as demonstrated by the newly observed perfect inverse sandwich D8h [La(η8-B8)La] and D9h [La(η9-B9)La]. Based on extensive global minimum searches and first-principles theory calculations, we predict herein the possibility of perfect endohedral trihedral metallo-borospherene D3h La@[La5&B30] (1, 3A’1) and its monoanion Cs La@[La5&B30] (2, 2A’) and dianion D3h La@[La5&B30]2- (3, 1A’1).

These La-doped boron clusters are composed of three inverse sandwich La(η8-B8)La on the waist and two inverse sandwich La(η9-B9)La on the top and bottom which share one apex La atom at the center and six periphery B2 units between neighboring η8-B8 and η9-B9 rings, with three octo-coordinate La atoms and two nona-coordinate La atoms as integrated parts of the cage surface.

Detailed adaptive natural density partitioning (AdNDP) and iso-chemical shielding surface (ICSS) analyses indicate that La@[La5&B30]0/-/2- (1/2/3) are spherically aromatic in nature. The one-dimensional nanowire La4B21 (4, Pm) constructed from D3h La@[La5&B30] (1) along the C3 axis of the system appears to be metallic. The IR and Raman spectra of La@[La5&B30] (1) and photoelectron spectroscopy of the slightly distorted Cs La@[La5&B30] (2) are theoretically simulated to facilitate their spectroscopic characterizations.

Towards the saving of global rainforests

Rainforests are the Earth’s largest terrestrial carbon sinks and are rapidly shrinking due to unprecedented human impact, especially tropical rainforests, which host ~50% of global biodiversity. Understanding what makes rainforests resilient on a long-term basis is key to preserving global rainforests and their ecological services.
Here, using estimates of rates-of-change (RoC) in fossil pollen records, an indicator for temporal compositional change (turnover) in vegetation, we show that accelerating trends in global rainforest changes (increasing RoC/turnover) during the last 12,000 years were mainly driven by intensive agricultural practices, and the highly diverse and productive tropical rainforests were the most impacted.
Management/conservation strategies aimed at the effective management of human impact will help promote rainforest health and diversity and increase resilience under projected climate change.

Serine Racemase (Recombinant)

  • 276.00 EUR
  • 1779.60 EUR
  • 393.60 EUR
  • 1 µg
  • 50 ug
  • 5 ug

Recombinant human Thymus-specific serine protease

100ug Ask for price

SRR Serine Racemase Human Recombinant Protein

Regular: 5ug 380.4 EUR

Serine Hydroxymethyltransferase 1 (Recombinant)

  • 4101.60 EUR
  • 393.60 EUR
  • 276.00 EUR
  • 1 mg
  • 20 ug
  • 5 ug

Protease Serine 3 (Recombinant)

  • 4101.60 EUR
  • 393.60 EUR
  • 276.00 EUR
  • 1 mg
  • 20 ug
  • 5 ug

Serine Dehydratase-Like (Recombinant)

  • 393.60 EUR
  • 7676.40 EUR
  • 276.00 EUR
  • 10 ug
  • 1 mg
  • 2 µg

Recombinant human Serine/threonine-protein kinase SBK2

100ug Ask for price

Recombinant human Serine/threonine-protein kinase Nek10

100ug Ask for price

Recombinant human Serine/threonine-protein kinase Sgk2

100ug Ask for price

Recombinant human Serine/threonine-protein kinase TAO1

100ug Ask for price

Fusogenic Viral Protein-Based Near-Infrared Active Nanocarriers for Biomedical

As a proof of concept, we bioengineered the vesicular stomatitis virus glycoprotein (VSV-G)-based near-infrared (NIR) active viral nanoconstructs (NAVNs) encapsulating indocyanine green dye (ICG) for NIR bioimaging.

NAVNs are spherical in size and have the intrinsic cellular-fusogenic properties of VSV-G. Further, the NIR imaging displaying higher fluorescence intensity in NAVNs treated cells suggests enhanced cellular uptake and delivery of ICG by NAVNs compared to the free form of ICG and for more information than visit joplink recombinant human to highlights. The overall study highlights the effectiveness of VSV-G-based VNPs as an efficient delivery system for NIR fluorescence imaging.

Phosphorylation of Trans-active response DNA binding protein-of 43 kDa promotes its cytoplasmic aggregation and modulates its function in tau mRNA stability and exon 10 alternative splicing

Trans-active response DNA-binding protein of 43 kDa (TDP-43) promotes tau mRNA instability and tau exon 10 inclusion. Aggregation of phosphorylated TDP-43 is associated with amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). CK1ε phosphorylates TDP-43 at multiple sites, enhances its cytoplasmic aggregation and modu-lates its function in tau mRNA processing.

To determine roles of TDP-43 site-specific phos-phorylation in its localization, aggregation, and function in tau mRNA processing, TDP-43 was mutated to alanine or aspartic acid at Ser379, Ser403/404, or Ser409/410 to block or mimic phosphorylation. Site-specific phosphorylation of TDP-43 and its mutants by CK1ε was studied in vitro and in cultured cells. Cytoplasmic and nuclear TDP-43 and phospho-TDP-43 were analyzed by Western blots.

Aggregation of TDP-43 was assessed by immunostaining and level of RIPA-insoluble TDP-43. GFP tailed with tau 3′-UTR and mini-tau gene pCI/SI9-LI10 were used to study tau mRNA stability and alternative splicing of tau exon 10. We found that phospho-blocking mutations of TDP-43 at Ser379, Ser403/404, or Ser409/410 were not effectively phosphorylated by CK1ε.

Compared with TDP-43, higher level of phosphorylated TDP-43 in the cytoplasm was observed. Phospho-mimicking mutations at these sites enhanced cytoplasmic aggregation of TDP-43. GFP expression was not inhibited by phospho-blocking mutants of TDP-43, but tau exon 10 inclusion was further enhanced by phospho-blocking mutations at Ser379 and Ser403/404. Phosphorylation of TDP-43 at Ser379, Ser 403/404 or Ser409/410 primes its phosphorylation by CK1ε, promotes TDP-43 cytoplasmic aggregation and modulates its function in tau mRNA processing in site-specific manner.

Oncogenic mutations Q61L and Q61H confer active form-like structural features to the inactive state (state 1) conformation of H-Ras protein

GTP-bound forms of Ras proteins (Ras•GTP) assume two interconverting conformations, “inactive” state 1 and “active” state 2. Our previous study on the crystal structure of the state 1 conformation of H-Ras in complex with guanosine 5′-(β, γ-imido)triphosphate (GppNHp) indicated that state 1 is stabilized by intramolecular hydrogen-bonding interactions formed by Gln61. Since Ras are constitutively activated by substitution mutations of Gln61, here we determine crystal structures of the state 1 conformation of H-Ras•GppNHp carrying representative mutations Q61L and Q61H to observe the effect of the mutations.

The results show that these mutations alter the mode of hydrogen-bonding interactions of the residue 61 with Switch II residues and induce conformational destabilization of the neighboring regions. In particular, Q61L mutation results in acquirement of state 2-like structural features. Moreover, the mutations are likely to impair an intramolecular structural communication between Switch I and Switch II. Molecular dynamics simulations starting from these structures support the above observations. These findings may give a new insight into the molecular mechanism underlying the aberrant activation of the Gln61 mutants.

Effect of Active Coatings Containing Lippa citriodora Kunth. Essential Oil on Bacterial Diversity and Myofibrillar Proteins Degradation in Refrigerated Large Yellow Croaker

The research evaluated the effects of locust bean gum (LBG) and sodium alginate (SA) active coatings containing 0.15, 0.30 or 0.60% lemon verbena (Lippa citriodora Kunth.) essential oil (LVEO) on the bacterial diversity and myofibrillar proteins (MPs) of large yellow croaker during refrigerated storage at 4 °C for 18 days. Variability in the dominant bacterial community in different samples on the 0, 9th and 18th day was observed.

. Pseudomonas and Shewanella were the two major genera identified during refrigerated storage. At the beginning, the richness of Pseudomonas was about 37.31% and increased for control (CK) samples during refrigerated storage, however, the LVEO-treated samples increased sharply from day 0 to the 9th day and then decreased.

LBG-SA coatings containing LVEO treatments significantly delayed MPs oxidation by retarding the formation of free carbonyl compounds and maintaining higher sulfhydryl content, higher Ca2+-ATPase activity, better organized secondary (higher contents of α-helix and β-sheet) and tertiary structures during refrigerated storage.

The transmission electron microscope (TEM) images showed that the integrity of the sarcomere was damaged; the boundaries of the H-, A-, and I-bands, Z-disk, and M-line were fuzzy in the CK samples at the end of storage. However, the LVEO-treated samples were still regular in appearance with distinct dark A-bands, light I-bands, and Z-disk. In brief, LBG-SA active coatings containing LVEO treatments suggested a feasible method for protecting the MPs of large yellow croaker during refrigerated storage.

Ribosome-Inactivating Proteins of Bougainvillea glabra Uncovered Polymorphism and Active Site Divergence

Ribosome-inactivating proteins (RIPs) are toxic proteins that can inhibit protein synthesis. RIPs purified from Bougainvillea have low nonspecific toxicity, showing promise for processing applications in the agricultural and medical fields. However, systematic research on the polymorphism of Bougainvillea RIPs is lacking, and it is worth exploring whether different isoforms differ in their active characteristics. The transcriptional and translational expression of type I RIPs in Bougainvillea glabra leaves was investigated in this study. Seven RIPs exhibited seasonal variation at both the mRNA and protein levels.

The isoforms BI4 and BI6 showed the highest transcriptional expression in both the summer and autumn samples. Interestingly, BI6 was not detected in the protein level in any of the samples. However, the bioinformatics analysis showed that RIPs derived from the same species were gathered in a different cluster, and that the active sites changed among the isoforms during evolution.

The significant discrepancy in Bougainvillea RIPs mainly locates at both termini of the amino acid sequence, particularly at the C terminus. Post-translational modifications may also exist in Bougainvillea RIPs. It is concluded that the reason for the polymorphism of Bougainvillea RIPs may be that these proteins are encoded by multiple genes due to genetic processes such as gene duplication and mutation. According to the results of sequence analysis, the possible functional differences of B. glabra RIP isoforms are discussed with regard to the observed discrepancy in both active sites and structures.

 

Mouse Complement Component 5a Receptor 1 (C5aR1) ELISA Kit

48T 609.6 EUR

Mouse Complement Component 5a Receptor 1 (C5aR1) ELISA Kit

96T 793.2 EUR

Mouse Complement Component 5a Receptor 1 (C5aR1) ELISA Kit

48 Tests 640.8 EUR

Mouse Complement Component 5a Receptor 1 (C5aR1) ELISA Kit

96 Tests 890.4 EUR

Mouse Complement Component 5a Receptor 1 (C5aR1) ELISA Kit

48 Tests 613.2 EUR

Mouse Complement Component 5a Receptor 1 (C5aR1) ELISA Kit

96 Tests 850.8 EUR

C5AR1 Recombinant Protein (Human)

100 ug Ask for price

C5ar1/ Rat C5ar1 ELISA Kit

96 Tests 1063.2 EUR

C5AR1 Recombinant Protein (Mouse)

100 ug Ask for price

C5AR1 Recombinant Protein (Mouse)

100 ug Ask for price

Resolving the formidable barrier of oxygen transferring rate (OTR) in ultrahigh-titer bioconversion/biocatalysis by a sealed-oxygen supply biotechnology (SOS).

Resolving the formidable barrier of oxygen transferring rate (OTR) in ultrahigh-titer bioconversion/biocatalysis by a sealed-oxygen supply biotechnology (SOS).

The vital situation within the competitiveness between bioengineering and chemical engineering is the merchandise titer and the amount productiveness. Essentially the most direct and efficient method normally employs high-density biocatalyst, whereas the weakened mass switch and evoked foam downside accompany ultrahigh-density biocatalyst loading and substrate/product titer.

In high-density obligate cardio bioconversion, oxygen as electron acceptor is a speed-limiting step in bioprocesses, however ample oxygen provide will result in the foaming which ends up in a big discount in oxygen utilization and the usage of further defoamers. On this examine, we designed a novel sealed-oxygen provide (SOS) biotechnology to resolve the formidable barrier of oxygen transferring price (OTR), for bio-based fuels and chemical manufacturing course of.

Outcomes

Based mostly on systemic evaluation of whole-cell catalysis in Gluconobacter oxydans, a novel sealed-oxygen provide expertise was neatly designed and experimentally carried out for biocatalytic oxidation of alcohols, sugars and so forth. By a easy operation ability of computerized on-line provide of oxygen in a sealed stirring tank bioreactor of SOS, OTR barrier and foaming downside was resolved with nice ease.

We lastly obtained ultrahigh-titer merchandise of xylonic acid (XA), 3-hydroxypropionic acid (3-HPA), and erythrulose at 588.four g/L, 69.four g/L, and 364.7 g/L, respectively. Furthermore, the amount productiveness of three chemical merchandise was improved by 150-250% in contrast with regular biotechnology. This SOS expertise offers a promising method to advertise bioengineering competitiveness and benefits over chemical engineering.

SOS expertise was demonstrated as an financial and universally relevant method to bio-based fuels and chemical substances manufacturing by whole-cell catalysis. The novel expertise drastically promotes the competitiveness of bioengineering for chemical engineering, and offers a promising platform for the inexperienced and environmental use of biofuels.

Resolving the formidable barrier of oxygen transferring rate (OTR) in ultrahigh-titer bioconversion/biocatalysis by a sealed-oxygen supply biotechnology (SOS).
Resolving the formidable barrier of oxygen transferring price (OTR) in ultrahigh-titer bioconversion/biocatalysis by a sealed-oxygen provide biotechnology (SOS).

Panel 1: Biotechnology, biomedical engineering and new fashions of otitis media.

To summarize not too long ago revealed key articles on the matters of biomedical engineering, biotechnology and new fashions in relation to otitis media (OM).Digital databases: PubMed, Ovid Medline, Cochrane Library and Scientific Proof (BMJ Publishing).Articles on biomedical engineering, biotechnology, materials science, mechanical and animal fashions in OM revealed between Might 2015 and Might 2019 have been recognized and subjected to overview. A complete of 132 articles have been finally included.

Mouse Epidermal Growth Factor Receptor (EGFR) ELISA Kit

DLR-EGFR-Mu-48T 48T
EUR 522
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Epidermal Growth Factor Receptor (EGFR) in samples from serum, plasma, tissue homogenates or other biological fluids.

Mouse Epidermal Growth Factor Receptor (EGFR) ELISA Kit

DLR-EGFR-Mu-96T 96T
EUR 673.2
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Epidermal Growth Factor Receptor (EGFR) in samples from serum, plasma, tissue homogenates or other biological fluids.

Rat Epidermal Growth Factor Receptor (EGFR) ELISA Kit

DLR-EGFR-Ra-48T 48T
EUR 544.8
Description: A sandwich quantitative ELISA assay kit for detection of Rat Epidermal Growth Factor Receptor (EGFR) in samples from serum, plasma or other biological fluids.

Rat Epidermal Growth Factor Receptor (EGFR) ELISA Kit

DLR-EGFR-Ra-96T 96T
EUR 704.4
Description: A sandwich quantitative ELISA assay kit for detection of Rat Epidermal Growth Factor Receptor (EGFR) in samples from serum, plasma or other biological fluids.

Human Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RD-EGFR-Hu-48Tests 48 Tests
EUR 501.6

Human Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RD-EGFR-Hu-96Tests 96 Tests
EUR 690

Mouse Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RD-EGFR-Mu-48Tests 48 Tests
EUR 514.8

Mouse Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RD-EGFR-Mu-96Tests 96 Tests
EUR 709.2

Rat Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RD-EGFR-Ra-48Tests 48 Tests
EUR 540

Rat Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RD-EGFR-Ra-96Tests 96 Tests
EUR 746.4

Human Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RDR-EGFR-Hu-48Tests 48 Tests
EUR 523.2

Human Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RDR-EGFR-Hu-96Tests 96 Tests
EUR 721.2

Mouse Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RDR-EGFR-Mu-48Tests 48 Tests
EUR 536.4

Mouse Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RDR-EGFR-Mu-96Tests 96 Tests
EUR 741.6

Rat Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RDR-EGFR-Ra-48Tests 48 Tests
EUR 564

Rat Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RDR-EGFR-Ra-96Tests 96 Tests
EUR 781.2

Human Epidermal Growth Factor Receptor (EGFR/Errb-1/HER1) ELISA Kit, 96 tests, quantitative

210-120-EGFR 1 kit
EUR 927.6

Mouse Epidermal Growth Factor Receptor (EGFR/Errb-1/HER1) ELISA Kit, 96 tests, quantitative

210-130-EGFR 1 Kit
EUR 927.6

EGFR Antibody

1-CSB-PA162597
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:15-1:50

EGFR Antibody

1-CSB-PA002264
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/40000

EGFR Antibody

1-CSB-PA002267
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/10000

EGFR Antibody

1-CSB-PA002273
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/40000

EGFR Antibody

1-CSB-PA002275
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000

EGFR Antibody

1-CSB-PA002281
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/5000

EGFR Antibody

1-CSB-PA10279A0Rb
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:500-1:1000

EGFR Antibody

1-CSB-PA007479GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB

EGFR Antibody

1-CSB-PA007971
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000

EGFR Antibody

1-CSB-PA007973
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/40000

EGFR Antibody

1-CSB-PA007976
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/5000

EGFR Antibody

1-CSB-PA007977
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000

EGFR Antibody

1-CSB-PA007978
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000

EGFR Antibody

AF6041 200ul
EUR 420

EGFR Antibody

AF6042 200ul
EUR 420

EGFR Antibody

AF6043 200ul
EUR 420

EGFR Antibody

AF6045 200ul
EUR 420

EGFR Antibody

AF6046 200ul
EUR 420

EGFR Antibody

AF6047 200ul
EUR 420

EGFR Antibody

AF6049 200ul
EUR 420

EGFR Antibody

AF6052 200ul
EUR 420

EGFR Antibody

AF0436 200ul
EUR 420

EGFR Antibody

1-CSB-PA005571LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EGFR. Recognizes EGFR from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF; Recommended dilution: WB:1:500-1:5000, IF:1:50-1:200

EGFR antibody

70R-37513 100 ug
EUR 327.6
Description: Rabbit Polyclonal EGFR antibody

EGFR antibody

70R-37514 100 ug
EUR 327.6
Description: Rabbit Polyclonal EGFR antibody

EGFR antibody

70R-49690 100 ul
EUR 344.4
Description: Purified Polyclonal EGFR antibody

EGFR antibody

70R-49691 100 ul
EUR 292.8
Description: Purified Polyclonal EGFR antibody

EGFR antibody

70R-34091 100 ug
EUR 392.4
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-34093 100 ug
EUR 392.4
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-34095 100 ug
EUR 392.4
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-34097 100 ug
EUR 392.4
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-34099 100 ug
EUR 392.4
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-34101 100 ug
EUR 392.4
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-35670 100 ug
EUR 392.4
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-33569 100 ug
EUR 392.4
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-51525 100 ul
EUR 344.4
Description: Purified Polyclonal EGFR antibody

EGFR antibody

70R-51526 100 ul
EUR 292.8
Description: Purified Polyclonal EGFR antibody

EGFR antibody

70R-30569 100 ug
EUR 392.4
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-30571 100 ug
EUR 392.4
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-31553 100 ug
EUR 392.4
Description: Rabbit polyclonal EGFR antibody

EGFR Antibody

48691-100ul 100ul
EUR 399.6

EGFR Antibody

48691-50ul 50ul
EUR 286.8

EGFR Antibody

48714-100ul 100ul
EUR 399.6

EGFR Antibody

48714-50ul 50ul
EUR 286.8

EGFR antibody

70R-11425 50 ug
EUR 236.4
Description: Rabbit polyclonal EGFR antibody for specific detection of the non-phosphorylated Ser1070 form of the EGFR peptide.

EGFR antibody

70R-12084 100 ul
EUR 523.2
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

70R-17018 50 ul
EUR 522
Description: Rabbit polyclonal EGFR antibody

EGFR Antibody

3782-100
EUR 405.6

EGFR antibody

38493-100ul 100ul
EUR 302.4

EGFR antibody

20R-2688 50 ug
EUR 337.2
Description: Goat polyclonal EGFR antibody

EGFR antibody

20R-2968 100 ul
EUR 471.6
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-ER004 250 µL
EUR 804
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-ER022 50 ug
EUR 787.2
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-ER023 50 ug
EUR 787.2
Description: Rabbit polyclonal EGFR antibody

EGFR Antibody

23630-100ul 100ul
EUR 468

EGFR Antibody

36836-100ul 100ul
EUR 302.4

EGFR antibody

20-ES04 250 ug
EUR 586.8
Description: Sheep polyclonal EGFR antibody

EGFR antibody

20R-1723 100 ug
EUR 807.6
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-1940 50 ug
EUR 337.2
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-1941 50 ug
EUR 337.2
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2032 50 ug
EUR 337.2
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2033 50 ug
EUR 337.2
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2062 50 ug
EUR 337.2
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2068 50 ug
EUR 337.2
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2069 50 ug
EUR 337.2
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2096 50 ug
EUR 337.2
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2177 50 ug
EUR 337.2
Description: Goat polyclonal EGFR antibody

EGFR antibody

20R-2254 50 ug
EUR 337.2
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2255 50 ug
EUR 337.2
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2356 50 ug
EUR 337.2
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2357 50 ug
EUR 337.2
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2376 50 ug
EUR 337.2
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2384 50 ug
EUR 337.2
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2385 50 ug
EUR 337.2
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

20R-2414 50 ug
EUR 337.2
Description: Rabbit polyclonal EGFR antibody

EGFR antibody

10R-1765 100 ul
EUR 379.2
Description: Mouse monoclonal EGFR antibody

EGFR antibody

10R-E101a 250 ug
EUR 1158
Description: Mouse monoclonal EGFR antibody

EGFR antibody

10R-3131 100 ul
EUR 379.2
Description: Mouse monoclonal EGFR antibody

EGFR Antibody

ABF0436 100 ug
EUR 525.6

EGFR Antibody

ABF6042 100 ug
EUR 525.6

EGFR Antibody

ABF6043 100 ug
EUR 525.6

EGFR Antibody

ABF6052 100 ug
EUR 525.6

EGFR Antibody

ABD7105 100 ug
EUR 525.6

EGFR Antibody

BF9105 200ul
EUR 540

EGFR Antibody

F47591-0.08ML 0.08 ml
EUR 165

EGFR Antibody

F49183-0.4ML 0.4 ml
EUR 379

Egfr Antibody

F52880-0.08ML 0.08 ml
EUR 165

Egfr Antibody

F52880-0.4ML 0.4 ml
EUR 379

EGFR Antibody

F40415-0.4ML 0.4 ml
EUR 389

EGFR Antibody

R31449 100 ug
EUR 419

EGFR Antibody

R35328-100UG 100 ug
EUR 399

EGFR Antibody

RQ4838 100ul
EUR 419

EGFR(GFR450) Antibody

BNCA0450-250 250uL
EUR 459.6
Description: Primary antibody against EGFR(GFR450), APC conjugate, Concentration: 0.1mg/mL

EGFR(H9B4) Antibody

BNCA0642-250 250uL
EUR 459.6
Description: Primary antibody against EGFR(H9B4), APC conjugate, Concentration: 0.1mg/mL

EGFR(B1D8) Antibody

BNCA0643-250 250uL
EUR 459.6
Description: Primary antibody against EGFR(B1D8), APC conjugate, Concentration: 0.1mg/mL

EGFR(31G7) Antibody

BNCA1194-250 250uL
EUR 459.6
Description: Primary antibody against EGFR(31G7), APC conjugate, Concentration: 0.1mg/mL

EGFR(GFR1195) Antibody

BNCA1195-250 250uL
EUR 459.6
Description: Primary antibody against EGFR(GFR1195), APC conjugate, Concentration: 0.1mg/mL

EGFR(GFR450) Antibody

BNCAP0450-100 100uL
EUR 238.8
Description: Primary antibody against EGFR(GFR450), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

EGFR(GFR450) Antibody

BNCAP0450-500 500uL
EUR 652.8
Description: Primary antibody against EGFR(GFR450), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

EGFR(H9B4) Antibody

BNCAP0642-100 100uL
EUR 238.8
Description: Primary antibody against EGFR(H9B4), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

EGFR(H9B4) Antibody

BNCAP0642-500 500uL
EUR 652.8
Description: Primary antibody against EGFR(H9B4), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

EGFR(B1D8) Antibody

BNCAP0643-100 100uL
EUR 238.8
Description: Primary antibody against EGFR(B1D8), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

EGFR(B1D8) Antibody

BNCAP0643-500 500uL
EUR 652.8
Description: Primary antibody against EGFR(B1D8), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

EGFR(31G7) Antibody

BNCAP1194-100 100uL
EUR 238.8
Description: Primary antibody against EGFR(31G7), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

EGFR(31G7) Antibody

BNCAP1194-500 500uL
EUR 652.8
Description: Primary antibody against EGFR(31G7), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

New imaging applied sciences for the tympanic membrane (TM) and the center ear cavity are being developed to evaluate TM thickness, establish biofilms and differentiate kinds of center ear effusions. Synthetic intelligence (AI) has been utilized to coach software program applications to diagnose OM with a excessive diploma of certainty. Genetically modified mice fashions for OM have additional investigated what predisposes some people to OM and consequent listening to loss. New vaccine candidates defending in opposition to main otopathogens are being explored and developed, particularly mixed vaccines, concentrating on multiple pathogen.

Transcutaneous vaccination in opposition to non-typeable Haemophilus influenzae has been efficiently tried in a chinchilla mannequin. When it comes to remedy, novel applied sciences for trans-tympanic drug supply are getting into the scientific area. Varied development components and grafting supplies geared toward enhancing therapeutic of TM perforations present promising leads to animal fashions.

New applied sciences and AI purposes to enhance the analysis of OM have proven promise in pre-clinical fashions and are steadily getting into the scientific area. So are novel vaccines and drug supply approaches that will permit native remedy of OM.New diagnostic strategies, potential vaccine candidates and the novel trans-tympanic drug supply present promising outcomes, however are usually not but tailored to scientific use.

Growing a circular economy with fungal biotechnology: a white paper.

Growing a circular economy with fungal biotechnology: a white paper.

Fungi have the power to remodel natural supplies right into a wealthy and various set of helpful merchandise and supply distinct alternatives for tackling the pressing challenges earlier than all people. Fungal biotechnology can advance the transition from our petroleum-based financial system right into a bio-based round financial system and has the power to sustainably produce resilient sources of meals, feed, chemical compounds, fuels, textiles, and supplies for building, automotive and transportation industries, for furnishings and past.

Fungal biotechnology affords options for securing, stabilizing and enhancing the meals provide for a rising human inhabitants, whereas concurrently reducing greenhouse gasoline emissions.

Fungal biotechnology has, thus, the potential to make a big contribution to local weather change mitigation and assembly the United Nation’s sustainable growth objectives by means of the rational enchancment of latest and established fungal cell factories.

The White Paper offered right here is the results of the 2nd Assume Tank assembly held by the EUROFUNG consortium in Berlin in October 2019. This paper highlights discussions on present alternatives and analysis challenges in fungal biotechnology and goals to tell scientists, educators, most people, industrial stakeholders and policymakers in regards to the present fungal biotech revolution.

 Growing a circular economy with fungal biotechnology: a white paper.
Rising a round financial system with fungal biotechnology: a white paper.

The Integration and Harmonisation of Secular and Islamic Moral Ideas in Formulating Acceptable Moral Pointers for Trendy Biotechnology in Malaysia.

The Malaysian authorities recognises the potential contribution of biotechnology to the nationwide financial system. Nonetheless, ongoing controversy persists relating to its moral standing and no particular moral pointers have been printed referring to its use. In creating such pointers, you will need to establish the underlying rules which might be acceptable to Malaysian society. This paper discusses the method of figuring out related secular and Islamic moral rules and establishing their similarities earlier than harmonising them.

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

DLR-EGFR2-Mu-48T 48T
EUR 544.8
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Epidermal Growth Factor Receptor 2 (EGFR2) in samples from serum, plasma, tissue homogenates or other biological fluids.

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

DLR-EGFR2-Mu-96T 96T
EUR 704.4
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Epidermal Growth Factor Receptor 2 (EGFR2) in samples from serum, plasma, tissue homogenates or other biological fluids.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

DLR-EGFR2-Ra-48T 48T
EUR 570
Description: A sandwich quantitative ELISA assay kit for detection of Rat Epidermal Growth Factor Receptor 2 (EGFR2) in samples from serum, plasma or other biological fluids.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

DLR-EGFR2-Ra-96T 96T
EUR 739.2
Description: A sandwich quantitative ELISA assay kit for detection of Rat Epidermal Growth Factor Receptor 2 (EGFR2) in samples from serum, plasma or other biological fluids.

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RDR-EGFR2-Hu-48Tests 48 Tests
EUR 549.6

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RDR-EGFR2-Hu-96Tests 96 Tests
EUR 759.6

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RDR-EGFR2-Mu-48Tests 48 Tests
EUR 564

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RDR-EGFR2-Mu-96Tests 96 Tests
EUR 781.2

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RDR-EGFR2-Ra-48Tests 48 Tests
EUR 594

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RDR-EGFR2-Ra-96Tests 96 Tests
EUR 822

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RD-EGFR2-Hu-48Tests 48 Tests
EUR 526.8

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RD-EGFR2-Hu-96Tests 96 Tests
EUR 727.2

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RD-EGFR2-Mu-48Tests 48 Tests
EUR 540

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RD-EGFR2-Mu-96Tests 96 Tests
EUR 746.4

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RD-EGFR2-Ra-48Tests 48 Tests
EUR 567.6

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

RD-EGFR2-Ra-96Tests 96 Tests
EUR 786

EGFR2 ELISA KIT|Human

EF006774 96 Tests
EUR 826.8

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody

20-abx103702
  • EUR 510.00
  • EUR 159.60
  • EUR 1412.40
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody

20-abx103703
  • EUR 393.60
  • EUR 978.00
  • EUR 510.00
  • EUR 184.80
  • EUR 309.60
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody

20-abx103704
  • EUR 526.80
  • EUR 159.60
  • EUR 1496.40
  • EUR 710.40
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody

20-abx130837
  • EUR 493.20
  • EUR 159.60
  • EUR 1378.80
  • EUR 678.00
  • EUR 376.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody

20-abx128593
  • EUR 493.20
  • EUR 159.60
  • EUR 1378.80
  • EUR 678.00
  • EUR 376.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody

20-abx172273
  • EUR 1045.20
  • EUR 543.60
  • 1 mg
  • 200 ug

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody

20-abx176304
  • EUR 1412.40
  • EUR 693.60
  • 1 mg
  • 200 ug

Active Epidermal Growth Factor Receptor 2 (EGFR2)

4-APB867Hu01
  • EUR 894.14
  • EUR 362.40
  • EUR 3023.04
  • EUR 1087.68
  • EUR 2055.36
  • EUR 674.40
  • EUR 7377.60
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Epidermal Growth Factor Receptor 2 expressed in: Available from E.coli, Yeast, Baculovirus and Mammalian cells

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

4-RPB867Hu01
  • EUR 550.08
  • EUR 271.20
  • EUR 1732.80
  • EUR 657.60
  • EUR 1195.20
  • EUR 444.00
  • EUR 4152.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Epidermal Growth Factor Receptor 2 expressed in: E.coli

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

4-RPB867Hu02
  • EUR 550.08
  • EUR 271.20
  • EUR 1732.80
  • EUR 657.60
  • EUR 1195.20
  • EUR 444.00
  • EUR 4152.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Epidermal Growth Factor Receptor 2 expressed in: E.coli

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

4-RPB867Mu01
  • EUR 588.79
  • EUR 280.80
  • EUR 1877.95
  • EUR 705.98
  • EUR 1291.97
  • EUR 469.20
  • EUR 4514.88
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse Epidermal Growth Factor Receptor 2 expressed in: E.coli

Recombinant Epidermal Growth Factor Receptor 2 (EGFR2)

4-RPB867Ra01
  • EUR 593.09
  • EUR 282.00
  • EUR 1894.08
  • EUR 711.36
  • EUR 1302.72
  • EUR 472.80
  • EUR 4555.20
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Rat Epidermal Growth Factor Receptor 2 expressed in: E.coli

Human Epidermal Growth Factor Receptor 2 (EGFR2) Protein

20-abx168780
  • EUR 777.60
  • EUR 326.40
  • EUR 2331.60
  • EUR 910.80
  • EUR 560.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human Epidermal Growth Factor Receptor 2 (EGFR2) Protein

20-abx066444
  • EUR 777.60
  • EUR 326.40
  • EUR 2331.60
  • EUR 910.80
  • EUR 560.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Rat Epidermal Growth Factor Receptor 2 (EGFR2) Protein

20-abx066445
  • EUR 828.00
  • EUR 343.20
  • EUR 2548.80
  • EUR 978.00
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) Protein

20-abx066447
  • EUR 828.00
  • EUR 343.20
  • EUR 2532.00
  • EUR 978.00
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody (FITC)

20-abx271123
  • EUR 560.40
  • EUR 292.80
  • EUR 1629.60
  • EUR 777.60
  • EUR 427.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody (FITC)

20-abx271195
  • EUR 594.00
  • EUR 309.60
  • EUR 1746.00
  • EUR 828.00
  • EUR 477.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody (Biotin)

20-abx271389
  • EUR 526.80
  • EUR 292.80
  • EUR 1513.20
  • EUR 727.20
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Epidermal Growth Factor Receptor 2 (EGFR2) Antibody (Biotin)

20-abx271461
  • EUR 560.40
  • EUR 292.80
  • EUR 1612.80
  • EUR 760.80
  • EUR 427.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human Epidermal Growth Factor Receptor 2 (EGFR2)ELISA Kit

201-12-2674 96 tests
EUR 528
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

20-abx151385
  • EUR 8534.40
  • EUR 4550.40
  • EUR 1054.80
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

20-abx155460
  • EUR 8853.60
  • EUR 4719.60
  • EUR 1093.20
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

20-abx153942
  • EUR 8684.40
  • EUR 4626.00
  • EUR 1074.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human Epidermal Growth Factor Receptor 2 (EGFR2) CLIA Kit

abx195583-96tests 96 tests
EUR 990

Monkey Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

abx359784-96tests 96 tests
EUR 904.8

Rabbit Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

abx363428-96tests 96 tests
EUR 904.8

Pig Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

abx361560-96tests 96 tests
EUR 904.8

Chicken Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

abx356052-96tests 96 tests
EUR 904.8

Human Epidermal Growth Factor Receptor 2 (EGFR2) CLIA Kit

20-abx493188
  • EUR 9567.60
  • EUR 5095.20
  • EUR 1177.20
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) CLIA Kit

20-abx493189
  • EUR 10282.80
  • EUR 5472.00
  • EUR 1262.40
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Rat Epidermal Growth Factor Receptor 2 (EGFR2) CLIA Kit

20-abx493190
  • EUR 9567.60
  • EUR 5095.20
  • EUR 1177.20
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

abx573292-96tests 96 tests
EUR 943.2

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

abx573464-96tests 96 tests
EUR 848.4

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human)

4-PAB867Hu01
  • EUR 286.80
  • EUR 2869.20
  • EUR 717.60
  • EUR 358.80
  • EUR 253.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2)

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Mouse)

4-PAB867Mu01
  • EUR 291.60
  • EUR 2948.40
  • EUR 735.60
  • EUR 366.00
  • EUR 254.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Epidermal Growth Factor Receptor 2 (EGFR2)

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Rat)

4-PAB867Ra01
  • EUR 301.20
  • EUR 3106.80
  • EUR 771.60
  • EUR 380.40
  • EUR 259.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Rat Epidermal Growth Factor Receptor 2 (EGFR2)

Human EGFR2(Epidermal Growth Factor Receptor 2) ELISA Kit

EH2981 96T
EUR 628.92
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 75pg/ml

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human)

4-MAB867Hu21
  • EUR 301.20
  • EUR 3098.40
  • EUR 769.20
  • EUR 379.20
  • EUR 258.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2)

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human)

4-MAB867Hu22
  • EUR 296.40
  • EUR 3027.60
  • EUR 753.60
  • EUR 373.20
  • EUR 256.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2)

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Hu-10x96wellstestplate 10x96-wells test plate
EUR 5402.92
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma, tissue homogenates and other biological fluids.

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Hu-1x48wellstestplate 1x48-wells test plate
EUR 550.13
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma, tissue homogenates and other biological fluids.

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Hu-1x96wellstestplate 1x96-wells test plate
EUR 734.46
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma, tissue homogenates and other biological fluids.

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Hu-5x96wellstestplate 5x96-wells test plate
EUR 2945.08
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma, tissue homogenates and other biological fluids.

Human Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

4-SEB867Hu
  • EUR 5463.60
  • EUR 2886.00
  • EUR 735.60
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Epidermal Growth Factor Receptor 2 (EGFR2) in samples from serum, plasma, tissue homogenates and other biological fluids with no significant corss-reactivity with analogues from other species.

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Mu-10x96wellstestplate 10x96-wells test plate
EUR 5552.14
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma, tissue homogenates and other biological fluids.

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Mu-1x48wellstestplate 1x48-wells test plate
EUR 562.42
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma, tissue homogenates and other biological fluids.

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Mu-1x96wellstestplate 1x96-wells test plate
EUR 752.02
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma, tissue homogenates and other biological fluids.

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Mu-5x96wellstestplate 5x96-wells test plate
EUR 3024.07
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma, tissue homogenates and other biological fluids.

Mouse Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

4-SEB867Mu
  • EUR 5612.40
  • EUR 2965.20
  • EUR 752.40
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Mouse Epidermal Growth Factor Receptor 2 (EGFR2) in samples from serum, plasma, tissue homogenates and other biological fluids with no significant corss-reactivity with analogues from other species.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Ra-10x96wellstestplate 10x96-wells test plate
EUR 5850.59
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma and other biological fluids.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Ra-1x48wellstestplate 1x48-wells test plate
EUR 586.99
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma and other biological fluids.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Ra-1x96wellstestplate 1x96-wells test plate
EUR 787.13
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma and other biological fluids.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

SEB867Ra-5x96wellstestplate 5x96-wells test plate
EUR 3182.08
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Epidermal Growth Factor Receptor 2 (EGFR2) in serum, plasma and other biological fluids.

Rat Epidermal Growth Factor Receptor 2 (EGFR2) ELISA Kit

4-SEB867Ra
  • EUR 5911.20
  • EUR 3122.40
  • EUR 787.20
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Rat Epidermal Growth Factor Receptor 2 (EGFR2) in samples from Serum, plasma and other biological fluids. with no significant corss-reactivity with analogues from other species.

Human Epidermal Growth Factor Receptor 2 ELISA Kit (EGFR2)

RK01301 96 Tests
EUR 625.2

Human Epidermal Growth Factor Receptor 2(EGFR2)ELISA Kit

QY-E04124 96T
EUR 433.2

CLIA kit for Human EGFR2 (Epidermal Growth Factor Receptor 2)

E-CL-H1044 1 plate of 96 wells
EUR 700.8
Description: A sandwich CLIA kit for quantitative measurement of Human EGFR2 (Epidermal Growth Factor Receptor 2) in samples from Serum, Plasma, Cell supernatant

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human), APC

4-PAB867Hu01-APC
  • EUR 399.60
  • EUR 3735.60
  • EUR 1046.40
  • EUR 507.60
  • EUR 258.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with APC.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human), Biotinylated

4-PAB867Hu01-Biotin
  • EUR 363.60
  • EUR 2809.20
  • EUR 836.40
  • EUR 442.80
  • EUR 259.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with Biotin.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human), Cy3

4-PAB867Hu01-Cy3
  • EUR 483.60
  • EUR 4930.80
  • EUR 1345.20
  • EUR 627.60
  • EUR 294.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with Cy3.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human), FITC

4-PAB867Hu01-FITC
  • EUR 344.40
  • EUR 3012.00
  • EUR 860.40
  • EUR 430.80
  • EUR 230.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with FITC.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human), HRP

4-PAB867Hu01-HRP
  • EUR 366.00
  • EUR 3256.80
  • EUR 926.40
  • EUR 459.60
  • EUR 243.60
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with HRP.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human), PE

4-PAB867Hu01-PE
  • EUR 344.40
  • EUR 3012.00
  • EUR 860.40
  • EUR 430.80
  • EUR 230.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with PE.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human, Rat)

4-PAB867Hu02
  • EUR 286.80
  • EUR 2869.20
  • EUR 717.60
  • EUR 358.80
  • EUR 253.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human, Rat Epidermal Growth Factor Receptor 2 (EGFR2)

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Mouse), APC

4-PAB867Mu01-APC
  • EUR 408.00
  • EUR 3843.60
  • EUR 1072.80
  • EUR 518.40
  • EUR 260.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with APC.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Mouse), Biotinylated

4-PAB867Mu01-Biotin
  • EUR 368.40
  • EUR 2888.40
  • EUR 856.80
  • EUR 450.00
  • EUR 260.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with Biotin.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Mouse), Cy3

4-PAB867Mu01-Cy3
  • EUR 493.20
  • EUR 5074.80
  • EUR 1381.20
  • EUR 642.00
  • EUR 297.60
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with Cy3.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Mouse), FITC

4-PAB867Mu01-FITC
  • EUR 350.40
  • EUR 3098.40
  • EUR 882.00
  • EUR 439.20
  • EUR 232.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with FITC.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Mouse), HRP

4-PAB867Mu01-HRP
  • EUR 373.20
  • EUR 3350.40
  • EUR 949.20
  • EUR 469.20
  • EUR 246.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with HRP.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Mouse), PE

4-PAB867Mu01-PE
  • EUR 350.40
  • EUR 3098.40
  • EUR 882.00
  • EUR 439.20
  • EUR 232.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with PE.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Rat), APC

4-PAB867Ra01-APC
  • EUR 422.40
  • EUR 4059.60
  • EUR 1126.80
  • EUR 540.00
  • EUR 267.60
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Rat Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with APC.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Rat), Biotinylated

4-PAB867Ra01-Biotin
  • EUR 379.20
  • EUR 3046.80
  • EUR 896.40
  • EUR 465.60
  • EUR 265.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Rat Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with Biotin.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Rat), Cy3

4-PAB867Ra01-Cy3
  • EUR 513.60
  • EUR 5362.80
  • EUR 1453.20
  • EUR 670.80
  • EUR 306.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Rat Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with Cy3.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Rat), FITC

4-PAB867Ra01-FITC
  • EUR 362.40
  • EUR 3271.20
  • EUR 925.20
  • EUR 456.00
  • EUR 237.60
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Rat Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with FITC.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Rat), HRP

4-PAB867Ra01-HRP
  • EUR 386.40
  • EUR 3537.60
  • EUR 996.00
  • EUR 488.40
  • EUR 252.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Rat Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with HRP.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Rat), PE

4-PAB867Ra01-PE
  • EUR 362.40
  • EUR 3271.20
  • EUR 925.20
  • EUR 456.00
  • EUR 237.60
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Rat Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with PE.

ELISA kit for Human EGFR2 (Epidermal Growth Factor Receptor 2)

ELK2233 1 plate of 96 wells
EUR 518.4
Description: A sandwich ELISA kit for detection of Epidermal Growth Factor Receptor 2 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

ELISA kit for Mouse EGFR2 (Epidermal Growth Factor Receptor 2)

ELK2659 1 plate of 96 wells
EUR 518.4
Description: A sandwich ELISA kit for detection of Epidermal Growth Factor Receptor 2 from Mouse in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

ELISA kit for Rat EGFR2 (Epidermal Growth Factor Receptor 2)

ELK5785 1 plate of 96 wells
EUR 518.4
Description: A sandwich ELISA kit for detection of Epidermal Growth Factor Receptor 2 from Rat in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), APC

4-MAB867Hu21-APC
  • EUR 422.40
  • EUR 4048.80
  • EUR 1124.40
  • EUR 538.80
  • EUR 266.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with APC.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), Biotinylated

4-MAB867Hu21-Biotin
  • EUR 379.20
  • EUR 3038.40
  • EUR 894.00
  • EUR 465.60
  • EUR 265.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with Biotin.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), Cy3

4-MAB867Hu21-Cy3
  • EUR 513.60
  • EUR 5348.40
  • EUR 1449.60
  • EUR 669.60
  • EUR 304.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with Cy3.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), FITC

4-MAB867Hu21-FITC
  • EUR 362.40
  • EUR 3262.80
  • EUR 922.80
  • EUR 454.80
  • EUR 236.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with FITC.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), HRP

4-MAB867Hu21-HRP
  • EUR 386.40
  • EUR 3528.00
  • EUR 993.60
  • EUR 487.20
  • EUR 250.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with HRP.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), PE

4-MAB867Hu21-PE
  • EUR 362.40
  • EUR 3262.80
  • EUR 922.80
  • EUR 454.80
  • EUR 236.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with PE.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), APC

4-MAB867Hu22-APC
  • EUR 415.20
  • EUR 3951.60
  • EUR 1100.40
  • EUR 529.20
  • EUR 264.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with APC.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), Biotinylated

4-MAB867Hu22-Biotin
  • EUR 374.40
  • EUR 2967.60
  • EUR 876.00
  • EUR 458.40
  • EUR 262.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with Biotin.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), Cy3

4-MAB867Hu22-Cy3
  • EUR 504.00
  • EUR 5218.80
  • EUR 1417.20
  • EUR 656.40
  • EUR 302.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with Cy3.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), FITC

4-MAB867Hu22-FITC
  • EUR 356.40
  • EUR 3184.80
  • EUR 903.60
  • EUR 447.60
  • EUR 235.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with FITC.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), HRP

4-MAB867Hu22-HRP
  • EUR 379.20
  • EUR 3444.00
  • EUR 973.20
  • EUR 478.80
  • EUR 248.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with HRP.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), PE

4-MAB867Hu22-PE
  • EUR 356.40
  • EUR 3184.80
  • EUR 903.60
  • EUR 447.60
  • EUR 235.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with PE.

ELISA kit for Human EGFR2 (Epidermal Growth Factor Receptor 2)

E-EL-H1629 1 plate of 96 wells
EUR 640.8
Description: A sandwich ELISA kit for quantitative measurement of Human EGFR2 (Epidermal Growth Factor Receptor 2) in samples from Serum, Plasma, Cell supernatant

ELISA kit for Mouse EGFR2 (Epidermal Growth Factor Receptor 2)

E-EL-M2666 1 plate of 96 wells
EUR 640.8
Description: A sandwich ELISA kit for quantitative measurement of Mouse EGFR2 (Epidermal Growth Factor Receptor 2) in samples from Serum, Plasma, Cell supernatant

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human), APC-Cy7

4-PAB867Hu01-APC-Cy7
  • EUR 656.40
  • EUR 7327.20
  • EUR 1948.80
  • EUR 872.40
  • EUR 372.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with APC-Cy7.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human, Rat), APC

4-PAB867Hu02-APC
  • EUR 399.60
  • EUR 3735.60
  • EUR 1046.40
  • EUR 507.60
  • EUR 258.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human, Rat Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with APC.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human, Rat), Biotinylated

4-PAB867Hu02-Biotin
  • EUR 363.60
  • EUR 2809.20
  • EUR 836.40
  • EUR 442.80
  • EUR 259.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human, Rat Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with Biotin.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human, Rat), Cy3

4-PAB867Hu02-Cy3
  • EUR 483.60
  • EUR 4930.80
  • EUR 1345.20
  • EUR 627.60
  • EUR 294.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human, Rat Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with Cy3.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human, Rat), FITC

4-PAB867Hu02-FITC
  • EUR 344.40
  • EUR 3012.00
  • EUR 860.40
  • EUR 430.80
  • EUR 230.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human, Rat Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with FITC.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human, Rat), HRP

4-PAB867Hu02-HRP
  • EUR 366.00
  • EUR 3256.80
  • EUR 926.40
  • EUR 459.60
  • EUR 243.60
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human, Rat Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with HRP.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human, Rat), PE

4-PAB867Hu02-PE
  • EUR 344.40
  • EUR 3012.00
  • EUR 860.40
  • EUR 430.80
  • EUR 230.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human, Rat Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with PE.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Mouse), APC-Cy7

4-PAB867Mu01-APC-Cy7
  • EUR 672.00
  • EUR 7543.20
  • EUR 2002.80
  • EUR 894.00
  • EUR 378.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with APC-Cy7.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Rat), APC-Cy7

4-PAB867Ra01-APC-Cy7
  • EUR 702.00
  • EUR 7975.20
  • EUR 2110.80
  • EUR 937.20
  • EUR 391.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Rat Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with APC-Cy7.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), APC-Cy7

4-MAB867Hu21-APC-Cy7
  • EUR 702.00
  • EUR 7953.60
  • EUR 2104.80
  • EUR 934.80
  • EUR 388.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with APC-Cy7.

Epidermal Growth Factor Receptor 2 (EGFR2) Monoclonal Antibody (Human), APC-Cy7

4-MAB867Hu22-APC-Cy7
  • EUR 686.40
  • EUR 7759.20
  • EUR 2056.80
  • EUR 915.60
  • EUR 384.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Mouse monoclonal antibody against Human Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with APC-Cy7.

Epidermal Growth Factor Receptor 2 (EGFR2) Polyclonal Antibody (Human, Rat), APC-Cy7

4-PAB867Hu02-APC-Cy7
  • EUR 656.40
  • EUR 7327.20
  • EUR 1948.80
  • EUR 872.40
  • EUR 372.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human, Rat Epidermal Growth Factor Receptor 2 (EGFR2). This antibody is labeled with APC-Cy7.

Cell permeable Inhibitor of EGFR2/FGFR/PDGFr/JAK1/Her2 ((E)-4-((4-)1H-1,2,3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole, mol wt 468; >98%)

SM-101050-10 10 mg
EUR 196.8

Cell permeable Inhibitor of EGFR2/FGFR/PDGFr/JAK1/Her2 ((E)-4-((4-)1H-1,2,3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole, mol wt 468; >98%)

SM-101050-100 100 mg
EUR 927.6

To attain this, a sequence of focus group discussions had been performed with 23 information consultants representing varied stakeholders within the biotechnology neighborhood. Notably, a number of rules between the secular and Islamic views are not directly or straight related.

All of the consultants agreed with the predominant six moral rules of secular and Islamic philosophy and their significance and relevance in trendy biotechnology.

These are beneficence and non-maleficence as the primary or overarching rules, the preservation of spiritual and ethical values, the preservation of the mind and the thoughts, the safety of human security, the safety of future generations, and safety of the surroundings and organic range. A number of changes had been made to the terminologies and definitions of those six rules to formulate acceptable guiding rules for the ethics of contemporary biotechnology in Malaysia.

These can then be adopted as core values to underpin future nationwide pointers on trendy biotechnology ethics. These rules can be notably essential in guiding the coverage makers, enforcers, industries and researchers to streamline their actions. In so doing, trendy biotechnology and its merchandise might be correctly managed with out jeopardising the pursuits of the Muslim neighborhood in addition to most people.

Importantly, they’re expansive and inclusive sufficient to embrace the non secular sensitivity of various quarters of Malaysia.

Argentina’s Local Crop Biotechnology Developments: Why Have They Not Reached the Market Yet?

Argentina's Local Crop Biotechnology Developments: Why Have They Not Reached the Market Yet?

Plant biotechnology in Argentina started at the end of the 1980s, leading to the development of numerous research groups in public institutions and, a decade later, to some local private initiatives. The numerous scientific and technological capacities existing in the country allowed the early constitution in 1991 of a sound genetically modified organisms biosafety regulatory system.

The first commercial approvals began in 1996, and to date, 59 events have obtained permits to be placed on the market, however, only two have been developed locally by public-private partnerships. The transgenic events developed at public institutions pursue different objectives in diverse crops.

However, once these events have been developed in laboratories, it is difficult to move toward a possible commercial approval. In this work, we analyze several reasons that could explain why local developments have not reached approvals for commercialization, highlighting aspects related to the lack of strategic vision in the institutions to focus resources on projects to develop biotechnological products.

Although progress has been made in generating regulatory rules adapted to research institutes (such as the regulations for biosafety greenhouses and ways of presenting applications), researchers still do not conceive regulatory science as a discipline. They generally prefer not to be involved in the design of regulatory field trials or regulatory issues related to the evaluation of events. In that sense, some of the aspects considered a regulatory affairs platform for the public scientific system and the reinforcement of laboratories that perform tests required under the Argentine regulation.

Argentina's Local Crop Biotechnology Developments: Why Have They Not Reached the Market Yet?
Argentina’s Local Crop Biotechnology Developments: Why Have They Not Reached the Market Yet?

Role of Business Models in Funding the Biotech Industry: Global Trends and Challenges for Cuban Biotechnology.

Forty-three years after it was founded, with billions of dollars invested, the global biotech industry is still not positioned as a mature low-risk sector for the international investor com-munity.

Despite the clear commercial success of a number of leading companies and overall growth of the industry’s rev-enues, most biotech companies are not profi table and many fail to overcome the formidable barrier constituted by the high cost of the sector’s research and development. However, over the last four years, visible signs of change have appeared, which could be harbingers of an approaching turning point in this trend.

This article analyzes the historic background of the biotech in-dustry’s business models and corporate structures, as well as their impact on the industry’s fi nancial framework. It examines recent changes implemented by the sector’s main actors-in-cluding young startups, venture capital funds and big pharma companies-to mitigate fi nancial risk associated with develop-ment of new biotechnology products.

EGTA

B7195-1000 1 g
EUR 127.2

EGTA

ED0077 25g
EUR 87.14

EGTA

GE7249-100G 100 g
EUR 180

EGTA

GE7249-10G 10 g
EUR 62.4

EGTA

GE7249-25G 25 g
EUR 84

EGTA

GE7249-50G 50 g
EUR 117.6

EGTA, 99%

GE9981-100G 100 g
EUR 217.2

EGTA, 99%

GE9981-10G 10 g
EUR 73.2

EGTA, 99%

GE9981-250G 250 g
EUR 399.6

EGTA, 99%

GE9981-25G 25 g
EUR 100.8

EGTA, 99%

GE9981-50G 50 g
EUR 144

EGTA-AM

HY-D0973 5mg
EUR 704.4

EGTA AM *CAS 99590-86-0*

21005 10 mg
EUR 211.2

EGTA AM *10 mM DMSO solution*

21006 1 mL
EUR 211.2

EGTA tetrasodium salt *CAS 13368-13-3*

21007 1 g
EUR 138

EGTA tetrasodium salt *10 mM aqueous solution*

21008 10 mL
EUR 138

2xRIPA Buffer IIII with EDTA and EGTA (pH 7.4) 2xconcentrate

RB4477 500ml
EUR 86.1

Finally, it discusses the challenges and opportunities that these tendencies entail for Cuban biotechnology development and proposes adoption of business policies more tolerant of the fi nancial risk inherent in this sector, as a condition for at-tracting venture capital. KEYWORDS Biotechnology, fund raising, risk management, entrepreneurship, Cuba.